Immunology, Microbiology & IBD
Thank you making our sessions at the 42nd annual DDW® in Chicago, IL scientifically relevant and exciting! If you have specific feedback regarding speakers sponsored by the Immunology, Microbiology and Inflammatory Bowel Diseases (IMIBD) section at DDW, please share your thoughts with us. We will do our best to consider your comments and concerns as we plan our program for next DDW 2012 in San Diego. We are now accepting volunteers for DDW 2012 abstract review and topic/speaker suggestions. Please visit the Volunteer and Feedback Form to get involved.
Two of our section's abstracts, A chimeric vaccine prevents primary and recurrent Clostridium difficile infection, and Cyclosporin Versus Infliximab In Severe Acute Ulcerative Colitis Refractory To Intravenous Steroids: A Randomized Trial were accepted for presentation at the very successful AGA Basic Science Plenary, and the Best of DDW 2011 Plenary and AGA Clinical Science Plenary sessions, respectively.
This year the IMIBD section accepted the majority of the abstracts submitted (77 percent). The accepted abstracts were designated as oral or poster presentations and of distinction based on their ranking by our dedicated abstract reviewers. The table below shows the change from last year:
|
IMIBD Abstract Selection |
2010 |
2011 |
|
Total Abstracts submitted |
911 |
968 |
|
Accepted Abstracts |
692 |
746 |
|
Oral Presentations |
127 |
147 |
|
Posters |
565 |
599 |
|
Posters of Distinction |
68 |
59 |
The IMIBD section sponsored Clinical, Research, and Translational Symposia, abstract based Research and Topic Fora, and one distinguished abstracts plenary. Our sessions were very well attended. The chart below outlines the sessions we sponsored at DDW 2011 and the number of people who attended the session. If you have feedback to share regarding any of these sessions please email Jennifer Gibson at AGA headquarters.
|
IMIBD Sessions |
|
|
|
Saturday, 5/7/2011 |
Duration |
Attendance |
|
Research Forum: Bedside to Benchtop in IBD |
8:30 – 10 a.m. |
118 |
|
Research Forum: Extraintestinal Effects of IBD |
8:30 – 10 a.m. |
310 |
|
Topic Forum: Prebiotics and Probiotics |
8:30 – 10 a.m. |
115 |
|
Research Forum: IBD Genetics |
10:30 – 12 p.m. |
142 |
|
Research Forum: Mechanisms of Bacterial Pathogenesis and Innate Immune Defense in the Intestine |
10:30 – 12 p.m. |
89 |
|
Research Forum: Surgical Issues in IBD |
10:30 – 12 p.m. |
263 |
|
Research Forum: Cancer and IBD |
.2:15 – 3:45 p.m. |
310 |
|
Research Symposium: Inflammatory Bowel Disease Pathogenesis: Recent Lessons Learned |
.2:15 – 3:45 p.m. |
260 |
|
Research Forum: Colitis-associated Cancer: Basic and Translational Mechanisms |
4 – 5:30 p.m. |
13 |
|
Research Forum: Therapeutic Monitoring in IBD |
4 – 5:30 p.m. |
413 |
|
Sunday, 5/8/2011 |
||
|
Research Forum: Imaging in IBD |
8:30 – 10 a.m. |
312 |
|
Research Forum: Epithelial Cell Function and Dysfunction in Inflammatory Bowel Disease |
. 10:30 – 12 p.m. |
225 |
|
Clinical Symposium: Controversies in IBD |
.2:15 – 3:45 p.m. |
1600 |
|
Immunology, Microbiology and Inflammatory Bowel Diseases Distinguished Abstracts Plenary |
4 – 5:30 p.m. |
750 |
|
Immunology, Microbiology and Inflammatory Bowel Diseases section Townhall Meeting |
5:30 – 6:30 p.m. |
unknown |
|
Monday, 5/9/2011 |
||
|
Research Forum: IBD: Epidemiology and Outcomes |
8:30 – 10 a.m. |
570 |
|
Research Forum: Innate Immune Mechanisms in IBD Pathogenesis |
8:30 – 10 a.m. |
275 |
|
Research Forum: Controlled Clinical Trials in IBD |
.2:15 – 3:45 p.m. |
1600 |
|
Translational Symposium: Stem Cells in Inflammatory Bowel Disease: Friend or Foe? |
.2:15 – 3:45 p.m. |
300 |
|
Research Forum: Endoscopy in IBD |
4 – 5:30 p.m. |
200 |
|
Research Forum: Host-microbial Interactions in Pathogenesis of Inflammatory Bowel Disease |
4 – 5:30 p.m. |
180 |
|
Tuesday, 5/10/2011 |
||
|
Research Forum: Novel Models of Intestinal Inflammation |
8:30 – 10 a.m. |
75 |
|
Research Forum: Prognostic Factors in IBD |
8:30 – 10 a.m. |
750 |
|
Research Symposium: Unlocking the Secrets of Host Microbial Interactions in Inflammatory Bowel Disease |
8:30 – 10 a.m. |
220 |
|
Research Forum: Adverse Outcomes and Infections in IBD |
10:30 – 12 p.m. |
145 |
|
Research Forum: Paneth Cells, Autophagy, and Anti-Bacterial Peptides In IBD Pathogenesis |
10:30 – 12 p.m. |
110 |
|
Research Forum: Animal Models of IBD: Interventions and Translational Implications |
.2:15 – 3:45 p.m. |
50 |
|
Clinical Symposium: Contemporary Therapeutic Dilemmas in IBD |
.2:15 – 3:45 p.m. |
700 |
Each June, IMIBD section descriptors are reviewed to optimize scientific relevance and minimize overlapping topics with other AGA Institute sections and to encourage both clinical research and basic science abstract submissions. The current list of abstract descriptors is as follows. (IMIBD descriptors may change as we go forward to DDW 2012.) We would like to thank our abstract review Committee Chairs and members for generously sharing their expertise and time in order to ensure that the most novel and relevant developments in Immunology, Microbiology and Inflammatory Bowel Diseases were shared at DDW.
|
Descriptor Name |
Abstracts Received |
Abstract Review Chair |
Abstract Reviewers |
|
IBD: Diagnostics in IBD |
47 |
Willem de Villiers |
Laurent Biroulet, Iris Dotan, Jonathan Leighton |
|
IBD: Disease Activity Assessment |
39 |
Simon Travis |
Peter Higgins, Thomas Ullman |
|
IBD: Therapeutic Monitoring |
67 |
Uma Mahadevan |
Geert D'Haens, Marla Dubinsky, Sunanda Kane |
|
IBD: Disease Complications |
61 |
Hillary Steinhart |
Laurent Beaugerie, Miguel Regueiro, Christian Stone |
|
IBD: Adverse Events Related to Therapy |
59 |
Charles Bernstein |
Laura Harrell, David Rubin, Corey Siegel |
|
IBD: Epidemiology |
49 |
Athos Bousvaros |
Gil Kaplan, Michael Kappelman, Geoffrey Nguyen |
|
IBD: Uncontrolled Therapeutic Observations in Humans |
69 |
Joshua Korzenik |
Asher Kornbluth, Gil Melmed |
|
IBD: Controlled Clinical Trials in Humans |
41 |
William Sandborn |
Brian Feagan, Hans Herfarth, Gert Van Assche |
|
IBD: Genetics |
64 |
Mark Silverberg |
Vito Annese, Richard Duerr |
|
Innate and Adaptive Immune Models of IBD |
17 |
Lee Denson |
Paul Beck, Atsushi Mizoguchi |
|
Animal Models: Pre-clinical Treatment of Intestinal Inflammation |
39 |
Pawel Kiela |
David Elliott, Sandra Kim, Jesus Rivera-Nieves |
|
Epithelial Cell Immune Function and Interactions with Immune Cells and Microbial Agents |
39 |
Kim Barrett |
Richard Blumberg, Elke Cario, Gerhard Rogler |
|
IBD: Immune Activation and Regulation |
54 |
Scott Snapper |
Claudio Fiocchi, Takanori Kanai, Stefan Shreiber |
|
IBD: Non-immune Cell Function, Activation and Regulation |
24 |
Barry Wershil |
John Kuemmerle, Ellen Zimmermann |
|
IBD: Cytokines, Signaling and Receptors |
46 |
Scott Snapper |
David Boone, Christian Jobin, Hans-Christian Reinecker |
|
Mucosal Innate Immune Function and Innate Host Defense |
39 |
Averil Ma |
Maria Abreu, Scott Plevy |
|
Novel Animal Models of IBD |
12 |
Mamoru Watanabe |
Clara Abraham, Masayuki Fukata |
|
Microbial-induced Mucosal Inflammation and Immunity |
55 |
Jonathan Braun |
Ingo Autenrieth, Charles Elson, Sarkis Mazmanian |
|
Prebiotics and Probiotics* |
44 |
Karen Madsen |
Andrew Gewirtz, Elena Verdu |
|
IBD: Natural History and Outcomes |
86 |
Jean Colombel |
Ashwin Ananthakrishnan, Edward Loftus, Fernando Velayos |
Note: Descriptors with an asterisk (*) are shared with at least one other Council section.
Section leaders will review committee membership this summer for new abstract review committees to confirm the final composition for DDW 2012 committees.
If you are interested in serving as a reviewer for any of our abstract descriptors for DDW 2012, please fill out this form to volunteer. Please indicate the abstract descriptor for which you are interested in reviewing. You can also recommend any new descriptors for abstracts. IMIBD section members interested in serving in this capacity are encouraged to contact us and volunteer to review abstracts. We are accepting volunteers through the end of July. You can join the IMIBD section at any time.
In addition, we encourage you to submit your invaluable ideas about the topics and invited speakers that you would like to hear at next year's DDW. The more specific you can be, the better (title, individual talks, speakers, learning objectives). Please fill out this form to submit your suggestions to the AGA Institute by July 1, 2011.
Members interested in participating in the various activities of the section should contact us at the addresses below. We are particularly interested in increasing participation by junior investigators/clinicians and international members at this time.
Thank you for your continuing strong support of the IMIBD section.
Sincerely,
Chair, IMIBD Section, AGA Institute Council
Vice-Chair, IMIBD Section, AGA Institute Council
